Dindolyl Methane, or DIM as it’s commonly known as, is a well-known supplement for bodybuilders as well as others who are interested in increasing the growth of their muscles. However there have been some recent reports of health risks that DIM could cause. DIM can cause liver damage if taken in excess. Another risk is kidney damage, which may result in kidney failure. The possible long term health risks of DIM make many bodybuilders and athletes think about the question: should I supplement my diet with a supplement with DIM?
The majority of people take diindolylmethane as a supplement to increase the production of testosterone. Testosterone is known to act as an anandrogen, meaning that it can cause hormonal changes in tissues. DIM has been demonstrated in studies to mimic the effects of testosterone, and other hormones. Because men produce much more testosterone than women do Certain manufacturers have added diindolylmethane to their products in order to make them more competitive in male circles. The idea is that men will respond to a product which mimics the effects of natural testosterone.
Many companies market DIM as a tumor suppressor. Although diindolylmethane can be effective in reducing tumor growth in laboratory animals, it was administered orally to the animals. To achieve the same result diindolylmethane needs to be taken in high doses for longer periods of period of time. The animals studied had no indications of cancer for a number of years. However, they all developed liver diseases after consuming too much diindolylmethane. To get a real glimpse of the way DIM works in the body, you should seek out a medical professional.
The only way to prove that DIM is effective in treating breast carcinoma is to conduct an experiment in which cells from healthy breast cells are exposed to high doses of diindolylmethane for an extended period of time. Like all chemicals there are pros and cons to using it. Its advantages include the ability to mimic hormones. This lets you create insulin which can inhibit cancer cell growth. The disadvantages are that diindolylmethane produces a harmful chemical called DMSO. Learn more about 3 3 diindolylmethane here.
One of the most popular claims for diindolylmethane’s use as treatment for various illnesses is that it is an natural, antibacterial, anti-cancer and anti-fungal drug. These claims were rejected by the National Institute of Health after an exhaustive review of the supporting data. According to the Institute of Chemical Technology there was no evidence from any research which supported this assertion. In a thorough study of the safety profile of the firestone the Institute of Chemical Safety concluded that the evidence from pharmaceutical companies on the benefits for humans of diindolylmethane was not substantiated.
Van der Goes, et. and. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. Van der Goes, and. identified the potential dangers of diindolylmethane usage, which include skin rash and allergic reactions, asthma attacks as well as dizziness, headaches and respiratory issues. The daily dosage recommended for this chemical, which is roughly one tenth of a teaspoon was 0.2 milligrams. It is unclear what the concentration will be when this chemical is combined with other compounds. This substance isn’t safe since it hasn’t been thoroughly tested.
The view abstract shows the use of diindolylmethane in cancer treatment is based on the principle that intracellular inhibition of pyruvate metabolism via flavenoids can be slowed down and stops the accumulation of Oxalates and pyruvate-derived metabolites in the renal tubule cells. However, the drug metabiplicate toxicology studies did not provide convincing evidence that consumption of this chemical results in an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the company that makes firestone tincture is in process of conducting two major studies – one in Europe and the other in the United States.
The view abstract also indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the principle of inhibiting the intracellular inhibition of pyruvate metabolite by flavenoids, thereby stopping the accumulation of oxalates within renal tubule cells and adenine granulocyte cultures. Metabiplicate toxicology studies on the drug have not demonstrated that this chemical can cause overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the company that makes firestone Tincture is currently conducting two major trials in Europe and the United States. According to the FDA, the manufacturer of firestone tincture is currently in the process of finishing two major trials in Europe and one in the United States.